[
    [
        {
            "time": "2018-03-15",
            "original_text": "Don't Sell Novo Nordisk A/S (CPH:NOVO B) Before You Read This",
            "features": {
                "keywords": [
                    "Novo Nordisk",
                    "Sell",
                    "Stock"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Don't Sell Novo Nordisk A/S (CPH:NOVO B) Before You Read This",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-03-15",
            "original_text": "Novo Nordisk A/S Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?",
            "features": {
                "keywords": [
                    "Novo Nordisk",
                    "Yearly Earnings",
                    "Analysts"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Novo Nordisk A/S Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        }
    ]
]